(Q46714781)

2 July 2019

title

Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers (English)

1 reference

2 July 2019

author name string

Malkhey Verma

1

1 reference

2 July 2019

Hans-Joerg Martin

2

1 reference

2 July 2019

Wahajul Haq

3

1 reference

2 July 2019

Timothy R O'Connor

4

1 reference

2 July 2019

Edmund Maser

5

1 reference

2 July 2019

Ganesaratnam K Balendiran

6

1 reference

2 July 2019

language of work or name

English

0 references

publication date

5 February 2008

1 reference

2 July 2019

European Journal of Pharmacology

published in

1 reference

2 July 2019

volume

584

1 reference

2 July 2019

issue

2-3

1 reference

2 July 2019

page(s)

213-221

1 reference

2 July 2019

Clinical pharmacokinetics of fibric acid derivatives (fibrates).

cites work

1 reference

12 December 2020

Fibrates inhibit aldose reductase activity in the forward and reverse reactions

1 reference

12 December 2020

Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients

1 reference

12 December 2020

Involvement of cysteine residues in catalysis and inhibition of human aldose reductase. Site-directed mutagenesis of Cys-80, -298, and -303

1 reference

12 December 2020

Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM

1 reference

12 December 2020

Physiological substrates of human aldose and aldehyde reductases

1 reference

12 December 2020

Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas.

1 reference

12 December 2020

Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group

1 reference

12 December 2020

Inhibition of aldehyde reductase by aldose reductase inhibitors

1 reference

12 December 2020

WY 14,643 inhibits human aldose reductase activity

1 reference

12 December 2020

Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention

1 reference

12 December 2020

Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat

1 reference

12 December 2020

Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system

1 reference

12 December 2020

Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer

1 reference

12 December 2020

A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil

1 reference

12 December 2020

Identification and characterization of a novel human aldose reductase-like gene

1 reference

12 December 2020

New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma

1 reference

12 December 2020

Fenofibrate and human liver. Lack of proliferation of peroxisomes

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?

1 reference

12 December 2020

Direct measurement of the rate of ring opening of D-glucose by enzyme-catalyzed reduction

1 reference

12 December 2020

The peroxisome proliferator-activated receptor alpha (PPARalpha): role in hepatocarcinogenesis

1 reference

12 December 2020

Affinity purification and glucose specificity of aldose reductase from bovine lens.

1 reference

12 December 2020

Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family

1 reference

12 December 2020

A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group

1 reference

12 December 2020

Cys298 is responsible for reversible thiol-induced variation in aldose reductase activity

1 reference

12 December 2020

Specifically targeted modification of human aldose reductase by physiological disulfides

1 reference

12 December 2020

Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens

1 reference

12 December 2020

NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT

1 reference

12 December 2020

Expect the unexpected or caveat for drug designers: multiple structure determinations using aldose reductase crystals treated under varying soaking and co-crystallisation conditions

1 reference

12 December 2020

Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases

1 reference

12 December 2020

1 reference

12 December 2020

A new nomenclature for the aldo-keto reductase superfamily.

1 reference

12 December 2020

Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism

1 reference

12 December 2020

10.1016/J.EJPHAR.2008.01.036

Identifiers

DOI

1 reference

2 July 2019

PMC publication ID

6193476

1 reference

2 July 2019

PubMed publication ID

18325492

1 reference

2 July 2019